These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Potassium Channels as Therapeutic Targets in Pulmonary Arterial Hypertension. Redel-Traub G; Sampson KJ; Kass RS; Bohnen MS Biomolecules; 2022 Sep; 12(10):. PubMed ID: 36291551 [TBL] [Abstract][Full Text] [Related]
4. Potassium Channel Subfamily K Member 3 (KCNK3) Contributes to the Development of Pulmonary Arterial Hypertension. Antigny F; Hautefort A; Meloche J; Belacel-Ouari M; Manoury B; Rucker-Martin C; Péchoux C; Potus F; Nadeau V; Tremblay E; Ruffenach G; Bourgeois A; Dorfmüller P; Breuils-Bonnet S; Fadel E; Ranchoux B; Jourdon P; Girerd B; Montani D; Provencher S; Bonnet S; Simonneau G; Humbert M; Perros F Circulation; 2016 Apr; 133(14):1371-85. PubMed ID: 26912814 [TBL] [Abstract][Full Text] [Related]
5. KCNK3: new gene target for pulmonary hypertension? Girerd B; Perros F; Antigny F; Humbert M; Montani D Expert Rev Respir Med; 2014 Aug; 8(4):385-7. PubMed ID: 24742047 [TBL] [Abstract][Full Text] [Related]
6. Comprehensive identification of signaling pathways for idiopathic pulmonary arterial hypertension. Liu B; Zhu L; Yuan P; Marsboom G; Hong Z; Liu J; Zhang P; Hu Q Am J Physiol Cell Physiol; 2020 May; 318(5):C913-C930. PubMed ID: 32159364 [TBL] [Abstract][Full Text] [Related]
7. A burden of rare variants in BMPR2 and KCNK3 contributes to a risk of familial pulmonary arterial hypertension. Higasa K; Ogawa A; Terao C; Shimizu M; Kosugi S; Yamada R; Date H; Matsubara H; Matsuda F BMC Pulm Med; 2017 Apr; 17(1):57. PubMed ID: 28388887 [TBL] [Abstract][Full Text] [Related]
8. A novel channelopathy in pulmonary arterial hypertension. Morita H; Komuro I N Engl J Med; 2013 Nov; 369(22):2161-2. PubMed ID: 24283238 [No Abstract] [Full Text] [Related]
9. A novel channelopathy in pulmonary arterial hypertension. Olschewski A; Nagaraj C; Olschewski H N Engl J Med; 2013 Nov; 369(22):2161. PubMed ID: 24283237 [No Abstract] [Full Text] [Related]
10. A novel channelopathy in pulmonary arterial hypertension. Chung WK; Sampson KS; Kass RS N Engl J Med; 2013 Nov; 369(22):2162. PubMed ID: 24283236 [No Abstract] [Full Text] [Related]
11. Characterization and regulation of wild-type and mutant TASK-1 two pore domain potassium channels indicated in pulmonary arterial hypertension. Cunningham KP; Holden RG; Escribano-Subias PM; Cogolludo A; Veale EL; Mathie A J Physiol; 2019 Feb; 597(4):1087-1101. PubMed ID: 30365877 [TBL] [Abstract][Full Text] [Related]
12. Molecular Analysis of BMPR2, TBX4, and KCNK3 and Genotype-Phenotype Correlations in Spanish Patients and Families With Idiopathic and Hereditary Pulmonary Arterial Hypertension. Navas P; Tenorio J; Quezada CA; Barrios E; Gordo G; Arias P; López Meseguer M; Santos-Lozano A; Palomino Doza J; Lapunzina P; Escribano Subías P Rev Esp Cardiol (Engl Ed); 2016 Nov; 69(11):1011-1019. PubMed ID: 27453251 [TBL] [Abstract][Full Text] [Related]